Esoteric Testing Market Set to Reach USD 61.27 Billion by 2032, Driven by Advancements in Molecular and Genomic Technologies – SNS Insider

SNS Insider Uncovers Strong Growth in the U.S. Esoteric Testing Market, Valued at USD 8.28 Billion in 2023, Driven by a Shift Toward Personalized Medicine, Cancer Genomics, and Advanced Diagnostic Technologies Across North America.

Austin, July 07, 2025 (GLOBE NEWSWIRE) -- Esoteric Testing Market Size & Growth Analysis:

According to SNS Insider, the global Esoteric Testing Market was valued at USD 25.88 billion in 2023 and is expected to reach USD 61.27 billion by 2032, expanding at a CAGR of 10.1% over the forecast period of 2024–2032.

Increasing incidence of complex and chronic diseases, such as cancer, rare genetic diseases, and autoimmune diseases, for which there is a need for more specialized diagnostics. Recent technologies, such as molecular biology, genomics, and next-generation sequencing, have led to more accurate and faster testing. Growing demand for personalized medicine and companion diagnostics is another factor boosting the market. This trend is further facilitated by the rising geriatric population, increased knowledge of the importance of early disease detection, and a developed healthcare infrastructure.

Get a Sample Report of Esoteric Testing Market@ https://www.snsinsider.com/sample-request/5461

The U.S. Esoteric Testing Market was estimated at USD 8.28 billion in 2023 and is expected to reach USD 19.43 billion by 2032, at a CAGR of 9.94% during the forecast period of 2024-2032

The North American esoteric testing market is led by the U.S., owing to the presence of advanced healthcare infrastructure and extensive practices of precision medicine, as well as robust investments in diagnostic technologies. Favorable reimbursement scenario, along with established authorities and presence of key players operating in the market, are anticipated to increase demand for specialized testing services in the country.

Major Players Analysis Listed in this Report are:

• Laboratory Corporation of America Holdings (Genetic Testing Services, Specialized Chemistry Testing)
• OPKO HEALTH, INC. (Hormone Replacement Therapy, Autoimmune Disease Testing)
• Quest Diagnostics Incorporated (Genetic Testing Services, Specialized Chemistry Testing)
• Sonic Healthcare Limited (Molecular Diagnostics, Clinical Pathology)
• H.U. Group Holdings, Inc. (Molecular Diagnostics, Clinical Pathology)
• Kindstar Globalgene Technology, Inc. (Genetic Testing Services, Personalized Medicine Testing)
• Stanford Health Care REIT (Clinical Trials and Research, Specialized Diagnostic Services)
• Mayo Foundation for Medical Education and Research (Clinical Trials and Research, Specialized Diagnostic Services)
• ARUP Laboratories (Molecular Diagnostics, Clinical Pathology)
• Athena Esoterix (Molecular Diagnostics, Clinical Pathology)
• ACM Global Laboratories (Molecular Diagnostics, Clinical Pathology)
• Healius Limited. (Molecular Diagnostics, Clinical Pathology)
• Fulgent Genetics (Genetic Testing Services, Personalized Medicine Testing)
• Healthscope (Pathology Services, Radiology Services)
• Essential Health Care REIT (Clinical Pathology, Molecular Diagnostics)
• Miraca Holdings (Molecular Diagnostics, Clinical Pathology)
• Spectra Laboratories (Molecular Diagnostics, Clinical Pathology)

Esoteric Testing Market Report Scope

Segment Analysis

Oncology Testing Segment is Anticipated to Hold the Largest Share of the Esoteric Testing Market by Type

In 2023, the oncology testing segment held the largest market share with 26%, driven by increasing global cancer incidence requiring novel diagnostic tools for early detection, prognosis, and therapy management. Molecular and genetic profiling and other cancer tests for esoteric oncology. An esoteric oncology test that looks for genetic or molecular changes can help find out if​ your cancer has a specific mutation or biomarker that can be treated with a targeted therapy.

Based on Technology, the Chemiluminescence Immunoassay Segment Accounted for the Largest Share of the Esoteric Testing Market

The drug development segment dominated the esoteric testing market in 2023 with a 30% market share, owing to its high sensitivity, specificity, and prompt turnaround, which is suitable for the identification of low-abundance biomarkers in complex diseases such as cancer and infectious diseases. It can be automated and done in a high-throughput format for large-scale diagnostics in hospitals and reference labs.

By Technology, Enzyme-Linked Immunosorbent Assay is Emerging as The Fastest-Growing Segment of the Esoteric Testing Market.

In 2023, the enzyme-linked immunosorbent assay segment held the largest share of the esoteric testing market, owing to its low cost, versatility, and ease of use. ELISA assays have been employed to detect not only antibodies but also antigens, proteins, and hormones in complex settings such as autoimmune diseases, infections, and tumors. It is suitable for low-throughput to high-throughput experiments, sensitive and specific, and is well-suited to research and diagnostic purposes.

For A Detailed Briefing Session with Our Team of Analysts, Connect Group with Us Now@ https://www.snsinsider.com/request-analyst/5461

Esoteric Testing Market Segmentation

By Type

• Oncology testing
• Infectious disease testing
• Genetic testing
• Endocrinology testing
• Toxicology testing
• Neurology testing
• Others

By Technology Type

• Chemiluminescence immunoassay
• Enzyme-linked immunosorbent assay
• Mass spectrometry
• Real-time polymerase chain reaction
• Flow cytometry
• Other

By End-use

• Hospital-based laboratories
• Independent and reference laboratories
• Others

By Specimen Type

• Blood, Serum, and Plasma
• Urine
• Other Specimens

Esoteric Testing Market is Expected to Register Fastest Growth in Asia-Pacific, North America Dominates.

The esoteric testing market in North America accounted for the largest share in 2023, with a 32% market share, owing to the superior health care system, great health care economy, and adoption of advanced diagnostic technology at an early stage. The area is home to numerous leading esoteric testing providers, clinical laboratories, and biotech companies.

The region Asia-Pacific is estimated to grow at the highest CAGR during the forecast period, owing to its increasing investment in healthcare, improving awareness of these advanced diagnostic technologies, and growing burden of chronic diseases. Moreover, growth in medical infrastructure, government initiatives, and an increase in the number of the geriatric population are also fueling demand for specialized testing in the developing economies, including China, India, and Japan.

Buy a Single-User PDF of Esoteric Testing Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/5461

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

6. Competitive Landscape

7. Esoteric Testing Market by Type

8. Esoteric Testing Market by Technology Type

9. Esoteric Testing Market by End-use

10. Esoteric Testing Market by Specimen Type

11. Regional Analysis

12. Company Profiles

13. Use Cases and Best Practices

14. Conclusion

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: info@snsinsider.com